Clinical Trial Update: High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing high versus standard doses of proton pump inhibitors for peptic ulcer bleeding has completed. The update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease
• Upper Gastrointestinal Bleeding

Drugs mentioned

• Proton pump inhibitors (PPIs) (proton pump inhibitors)

Snippet

Sponsor: Casa Sollievo della Sofferenza IRCCS | Conditions: Peptic Ulcers, Upper Gastrointestinal Bleeding | Phase 3 | Status: COMPLETED